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Recently we reported the characterization of simian immunodeficiency virus (SIVlhoest) from a central
African l’hoest monkey (Cercopithecus lhoesti lhoesti) that revealed a distant relationship to SIV isolated from
a mandrill (SIVmnd). The present report describes a novel SIV (SIVsun) isolated from a healthy, wild-caught
sun-tailed monkey (Cercopithecus lhoesti solatus), another member of the l’hoest superspecies. SIVsun repli-
cated in a variety of human T-cell lines and in peripheral blood mononuclear cells of macaques (Macaca spp.)
and patas monkeys (Erythrocebus patas). A full-length infectious clone of SIVsun was derived, and genetic
analysis revealed that SIVsun was most closely related to SIVlhoest, with an amino acid identity of 71% in Gag,
73% in Pol, and 67% in Env. This degree of similarity is reminiscent of that observed between SIVagm isolates
from vervet, grivet, and tantalus species of African green monkeys. The close relationship between SIVsun and
SIVlhoest, despite their geographically distinct habitats, is consistent with evolution from a common ancestor,
providing further evidence for the ancient nature of the primate lentivirus family. In addition, this observation
leads us to suggest that the SIVmnd lineage should be designated the SIVlhoest lineage.
Simian immunodeficiency viruses (SIV) and the closely re-
lated human immunodeficiency viruses (HIV-1 and HIV-2)
belong to the lentivirus subfamily of retroviruses. At present
these primate lentiviruses can be classified into five lineages
based upon the sequence and functional similarity of their
genes (31, 62). These five lineages are represented by (i)
SIVcpz from chimpanzees (Pan troglodytes) together with
HIV-1 (19, 34, 35, 54, 68), (ii) SIVsm from sooty mangabeys
(Cercocebus torquatus atys) together with HIV-2 (10, 33, 46, 55,
58), (iii) SIVagm from four species of African green monkeys
(members of the Chlorocebus aethiops superspecies) (4, 6, 12,
16, 32, 36, 38, 47), (iv) SIVsyk from Sykes’ monkeys (Cerco-
pithecus mitis albogularis) (13, 30), and (v) SIVmnd from a
mandrill (Mandrillus sphinx) together with SIVlhoest from
l’hoest monkeys (Cercopithecus lhoesti lhoesti) (28, 66, 67).
The phylogenetic relationships of these viruses exhibit little
correlation with those of the host primate species, indicating
that cross-species transmissions have occurred on numerous
occasions (62). Most notably, the two groups of viruses giving
rise to AIDS in humans both appear to have resulted from
multiple independent transmissions from other species. It has
been clear for some time that feral sooty mangabeys are the
source of the HIV-2 epidemic in West Africa (10, 20, 21, 46),
while very recent work has implicated chimpanzees of the
subspecies P. troglodytes troglodytes in Central Africa as the
natural reservoir of HIV-1 (19, 34, 35, 53, 54, 68). Other
transmissions have occurred both in captivity and in the wild.
For example, SIV infection of several species of macaques
(Macaca spp.) has resulted from accidental introduction of
SIVsm in North American primate centers (22, 27, 50), while
a yellow baboon (Papio hamadryas cynocephalus) in Tanzania
(37), a chacma baboon (Papio ursinus) in South Africa (69),
and a patas monkey (Erythrocebus patas) in Senegal (8) have
each become infected in the wild by viruses derived from the
local sympatric species of African green monkeys. These ex-
amples all reflect comparatively recent cross-species transmis-
sion events, readily identifiable by virus-host phylogenetic dis-
cordance within the major primate lentivirus lineages. In
addition, deeper branchings within the phylogeny are at odds
with the relationships among the species inferred to be the
natural host for each lineage. The five major viral lineages are
approximately equidistant, and yet four comprise viruses nat-
urally infecting Cercopithecidae (Old World monkeys) while
the fifth is found in apes. Furthermore, it is remarkable that
the recently characterized SIVlhoest falls within the same lin-
eage as SIVmnd (28), since l’hoest monkeys are closely related
to other members of the genus Cercopithecus while mandrills
are more closely related to mangabeys (Cercocebus spp.) (25).
Thus, cross-species transmissions greatly complicate any at-
tempts to determine the evolutionary origins of this group of
viruses or the timescale of primate infection. For this reason, it
is of interest to identify groups of viruses that may have evolved
in a host-dependent fashion.
There is evidence of host-dependent evolution of lentivi-
ruses among African green monkeys (4, 32, 38, 47). However,
the viruses identified to date may represent only a small frac-
tion of the lentiviruses present in African primates. Recently,
SIVs from red-capped mangabeys (Cercocebus torquatus tor-
quatus) (SIVrcm) and drills (Mandrillus leucophaeus) (SIVdrl)
have been partially characterized (11, 24). In addition, sero-
logical surveys have indicated that DeBrazza monkeys (Cerco-
pithecus neglectus), moustached monkeys (Cercopithecus ce-
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phus), Diana monkeys (Cercopithecus diana), greater white-
nosed monkeys (Cercopithecus nictitans), talapoins (Miopithecus
talapoin), Allen’s swamp monkeys (Allenopithecus nigroviridis),
and colobus monkeys (Colobus guereza) may all harbor lenti-
viruses (45, 51, 65).
In our efforts to elucidate the origins and evolution of the
primate lentiviruses, we obtained blood samples from 13 wild-
caught monkeys, representing six different species, from West
Africa. Plasma samples of three Campbell’s monkeys (Cerco-
pithecus campbelli) and one sun-tailed monkey (Cercopithecus
lhoesti solatus) contained antibodies that were cross-reactive
with SIVagm antigens. However, a virus with a Mg21-depen-
dent reverse transcriptase (RT) activity could be isolated only
from the SIV-positive sun-tailed monkey. The new viral isolate
was designated SIVsun according to its species of origin. The
sun-tailed monkey is a rare species, inhabiting the Foreˆt des
Abeilles (Forest of the Bees), a restricted area of about 10,300
km2 in Gabon (9), and was first described in 1984 (26). SIVsun
is of particular interest because sun-tailed and l’hoest monkeys
are classified within the same superspecies, indicating that they
are considered to be closely related. This paper describes the
biological and genetic characterization of SIVsun.
MATERIALS AND METHODS
Animals, serologic testing, and virus isolation. Blood samples from five Camp-
bell’s monkeys (Cercopithecus campbelli), two greater white-nosed monkeys (Cer-
copithecus nictitans), two red-eared monkeys (Cercopithecus erythrotis), two sun-
tailed monkeys (Cercopithecus lhoesti solatus), one grey-cheeked mangabey
(Lophocebus albigena), and one red-capped mangabey (Cercocebus torquatus
torquatus) were obtained. All the animals had been caught in the wild in West
and Central Africa (Table 1). Plasma samples from the animals were tested by
enzyme-linked immunosorbent assay (ELISA) with whole SIVagm lysate, by
Western blot analysis against SIVagm or HIV-1 and HIV-2 (Genelabs Diagnos-
tics, Singapore, Singapore), and by radioimmunoprecipitation (RIPA) with
SIVsmH4 virus and cell lysate. Subsequently, peripheral blood mononuclear cells
(PBMC) from the animals that appeared to be seropositive by at least one of
these assays were cocultivated with the human T-cell lines C8166 or
MOLT4clone8 (M4C8) to isolate SIVs. Antibodies to human T-lymphotropic
virus (HTLV) types 1 and 2 were tested with commercial Western blot strips
(Murex Biotech Ltd., Dartford, United Kingdom).
Cells, production of virus stocks, and in vitro infectivity studies. The human
CD41 cell lines, MT2, MT4, H9, U937, SupT1, C8166, CEMss, CEM174, PM1,
Hut78, and M4C8 were maintained in RPMI complete medium (RPMI 1640,
supplemented with 10% heat-inactivated fetal calf serum, 2 mM glutamine, 100
U of penicillin per ml, 100 mg of streptomycin per ml, and 10 mM HEPES).
PBMC were separated by Ficoll-Hypaque density gradient centrifugation of
whole blood, and 107 cells were stimulated with 2 mg of phytohemagglutinin
(PHA; Sigma, St. Louis, Mo.) per ml for 3 days and then maintained in RPMI
complete medium, supplemented with 5 half-maximal units of human interleu-
kin-2 (Advanced Biotechnologies, Columbia, Md.) per ml. Virus stocks were
produced on CEMss cells by harvesting the supernatant at the peak of RT
activity, filtering it through a 0.45-mm-pore-size filter, and cryopreserving the
stocks in the vapor phase of liquid nitrogen. Titers of virus stocks were deter-
mined on CEMss and C8166 cells by using threefold dilutions and used to infect
human CD41 cell lines or monkey PBMC at a multiplicity of infection (MOI) of
0.01. The cells were infected for 4 h, washed three times with Hanks’ buffered salt
solution (HBSS), and then resuspended in 3 ml (cell lines) or 10 ml (PBMC) of
RPMI complete medium. Cell-free supernatants were taken at regular intervals
for the measurement of RT activity (52) combined with medium exchange.
Lymphocyte immunophenotyping. Lymphocyte subsets (CD3, CD4, CD8, and
CD20) were measured by fluorescence-activated cell sorter analysis with a
Coulter EPICS XL-MCL instrument (assays were performed by FAST Systems,
Inc., Gaithersburg, Md.). Monkey peripheral blood leukocytes were stained with
monoclonal antibodies conjugated to fluorescein isothiocyanate (FITC), phyco-
erythrin (PE), or PerCP. EDTA whole-blood samples were incubated for 30 min
in the dark at 4°C in the presence of sodium azide with the appropriate mono-
clonal antibody conjugate. Following staining, the erythrocytes were lysed and
the leukocytes were fixed in 1% paraformaldehyde and analyzed with the Coulter
EPICS XL-MCL instrument. Several human monoclonal antibodies to cell sur-
face markers were tested, and the ones with the highest cross-reactivity were used
for immunophenotyping: rhesus anti-CD3–PE (from M. Rosenzweig, Harvard
University) to identify total T lymphocytes, OKT4A-FITC (Ortho Diagnostic
Systems, Raritan, N.J.) to identify CD41 lymphocytes, Leu2A-PerCP (Becton
Dickinson, Franklin Lakes, N.J.) to identify CD81 lymphocytes, and Leu16-
TABLE 1. Serological survey of different wild-caught primate species
Species (common name) Sexa Origin Age (yr)
Result of:
SIVagm ELISA
(titer)
SIVagm
Western blot
HIV-1/2
Western blotb SIVsmH4 RIPA
HTLV
Western blotc
Cercopithecus campbelli
(Campbell’s monkey)
M Sierra Leone 12 2 2 2 2 2
F Sierra Leone 26 1 (3,768) 1 (p24) 1 (p24) 1 (p24, gp120/160) 2
F Sierra Leone 11 1 (2,925) 2 2 1 (gp160) 2
F Sierra Leone 11 NDd 1 (p24) ND 1 (p24, gp120/160) 2
F Sierra Leone 14 ND 2 ND 2 2
Cercopithecus nictitans
(greater white-nosed monkey)
F Gabon 21 2 ND 2 ND 2
M ? 12 2 ND 2 ND 2
Cercopithecus erythrotis
(red-eared monkey)
M Cameroon 13 2 2 2 2 2
F Cameroon 16 2 2 2 2 2
Cercopithecus lhoesti solatus
(sun-tailed monkey)
M Gabon 13 2 ND 2 2 2
M Gabon 9 1 (4,463) ND 1 (gp160) 1 (gp160) 2
Lophocebus albigena
(grey-cheeked mangabey)
F Gabon 23 2 ND 2 ND 2
Cercocebus torquatus torquatus
(red-capped mangabey)
F ? 16 ND ND 2 ND 2
a M, male; F, female.
b Genelabs Diagnostics, Singapore, Singapore.
c Murex Biotech Ltd., Dartford, England. RIPA, radioimmunoprecipitation.
d ND, not done.
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FITC (Becton Dickinson) to identify CD20-expressed on B lymphocytes. Leu-
kocyte counts were measured with a Technicon H1*E hematology instrument.
Absolute lymphocyte counts were determined by differentiating the lymphocytes,
monocytes, and granulocytes by light scattering on the Coulter EPICS XL-MCL
flow cytometer and multiplying the lymphocyte percentage by the leukocyte
count.
Neutralizing-antibody assay. Heat-inactivated plasma (56°C for 20 min) from
the sun-tailed monkeys were serially diluted threefold in tissue culture microtiter
plates (20 ml per well; four replicates and six dilution steps) beginning with a 1:2
dilution. A total of 100 50% tissue culture infective doses (TCID50) of SIVsun,
grown in CEMss cells, was added in an equivalent volume (20 ml) per well, mixed
with the virus by pipetting, and incubated at 37°C for 1 h. A 160-ml volume of
PHA-stimulated pigtailed macaque PBMC (105 cells) was added to each well,
and the plates were incubated for 7 days before they were scored for RT activity.
The following controls were included in the assay: (i) virus and cells (no-plasma
control) (ii) cells alone (no-virus control), and (iii) virus alone (no-cell control).
RIPA. CEMss or CEM174 cells were infected with SIV and, at the peak of RT
activity, labeled overnight with L-[35S]methionine and L-[35S]cysteine (Amer-
sham, Arlington Heights, Ill.). The next day, the labeled cells were lysed with 1
ml of RIPA buffer (20 mM Tris-HCl [pH 7.5], 5 mM EDTA [pH 8.0], 312.5 mM
NaCl, 1.0 g of sodium deoxycholate, 1% Nonidet P-40) and centrifuged, and the
cell lysate supernatant was preabsorbed with 50 ml of protein A-agarose beads
(Gibco BRL, Gaithersburg, Md.) for 1 h. A 10-ml volume of plasma was com-
bined with 50 ml of the protein A-agarose beads and incubated with shaking for
1 h at 4°C. The protein A-agarose bead-antibody complex was washed once with
phosphate-buffered saline, combined with 100 ml of the cell lysate, incubated
with shaking for 1 h at 4°C, and then washed five times with 1 ml of RIPA buffer.
The pellet was resuspended in 50 ml of RIPA buffer and 50 ml of 23 sodium
dodecyl sulfate (SDS) gel-loading buffer (100 mM Tris-HCl [pH 6.8], 200 mM
2-mercaptoethanol, 4% SDS, 0.2% bromophenol blue, 20% glycerol), boiled for
4 min, and then loaded onto an SDS–10% polyacrylamide gel. The dried gel was
exposed to Bio-Max MR film (Kodak, Rochester, N.Y.) for 3 days. The poly-
clonal plasma used for precipitation originated from the naturally SIV-infected
sun-tailed monkey (a-SIVsun, two different blood draws); from macaques ex-
perimentally infected with SIVlhoest-P (a-SIVlhoest), SIVagmVer(3) (a-
SIVagm), SIVsmF236 (a-SIVsm), or SIVmac251/32H (a-SIVmac); and from
HIV-infected humans (a-HIV-1 and a-HIV-2). The a-HIV-1 plasma consisted
of a pool collected from several individuals.
PCR amplification and plasmid cloning. Total cellular DNA was extracted
from infected C8166 cells by conventional methods. For amplification of the gag
sequence, the following primer pairs, which were chosen from regions that were
conserved between SIVlhoest and SIVmndGB1, were used. The primers con-
tained XhoI and Csp45I restriction sites (underlined) to facilitate cloning: lhoest
gag F (59-CTAGCTCGAGGCGCCCGAACAGGGACTTCAAG-39) and lhoest
gag R (59-ATTCATTCGAACTATTGGTCGTCTGGAAAGAG-39). The con-
ditions for the amplification were 30 cycles of 94°C for 1 min, 55°C for 1.5 min,
and 72°C for 2 min. The resulting 1,856-bp (gag) fragment was cloned into the
pGEM-7Zf plasmid vector (Promega, Madison, Wis.) and subsequently used as
a probe for Southern hybridization and screening of a bacteriophage lambda
library.
Bacteriophage lambda cloning. A variety of restriction enzymes were evalu-
ated by Southern blot hybridization of total DNA from infected C8166 cells by
using the 1,856-bp gag fragment as a probe. All enzymes useful for lambda
cloning had restriction sites within the SIVsun genome, and thus EcoRI, which
cleaved once within the genome, was chosen for lambda cloning to yield a 8.6-kb
viral fragment. Total cellular DNA was digested to completion with EcoRI,
fractionated over a 20 to 60% sucrose gradient to obtain 9- to 20-kb fragments,
and ligated into EcoRI-cleaved arms of the lDASHII vector (Stratagene, La
Jolla, Calif.). Ligation products were packaged in vitro (Gigapack Gold III;
Stratagene) and subjected to titer determination on Escherichia coli K802. A
total of 8.3 3 105 recombinant plaques were screened, using a [32P]dCTP-labeled
gag fragment (Multiprime DNA labeling system; Amersham), and the hybridized
blotting filters were exposed to Kodak X-Omat AR film. Six positive clones were
detected and plaque purified. The restriction enzyme SmaI was used to reduce
the cellular sequences flanking the 59 long terminal repeat (LTR) to 4 kb, and the
complete clone was ligated as a SmaI-EcoRI fragment (L14) into the pGEM7Zf
plasmid vector to facilitate further cloning strategies. The missing 1.4-kb 39 part
of the full-length virus was generated by PCR with primers 3322 (59-AAGTAG
TACCAGCTCCACTGC-39) and 3323 (59-ATGCCTCGAGTGCTAGCCGTC
AGCCCCGGAT-39). Primer 3323 contained a XhoI restriction site (under-
lined). The PCR fragment (S2) was digested with XhoI and partially with EcoRI
(since the fragment contained two EcoRI sites) and cloned into pGEM7Zf
plasmid vector. Both virus fragments (8.6 and 1.4 kb) were sequenced by auto-
mated fluorescence sequencing (Taq amplification/termination; Perkin- Elmer
Applied Biosystems, Warrington, United Kingdom). Finally, the 1.4-kb fragment
was ligated into the linearized plasmid containing the 12.6-kb fragment to
achieve the full-length replication-competent molecular clone SIVsunl20(L14/
S2).
Sequence comparisons. The predicted protein sequences encoded by SIVsun
were compared to the following representatives of the major lentivirus lineages:
HIV-1 subtype A (isolate U455; GenBank accession no. M62320), subtype B
(BRU; K02013), and group O (MVP5180; L20571); SIVcpz strains Gab
(X52154) and Ant (U42720); SIVsm (PBj; M31325); HIV-2 subtype A (ROD;
M15390) and subtype B (EHOA; U27200); SIVagm from vervets (ver155;
M29975), grivets (gri-1; M58410), and tantalus (tan-1; U58991); SIVsyk (173;
L06042); SIVmnd (GB1; M27470); and SIVlhoest (AF075269). Protein se-
quences were aligned by using ClustalX (64), with minor manual adjustment with
SEAVIEW (18). Sites that could not be aligned unambiguously, as well as sites
containing a gap in any of the sequences, were excluded from the analyses. The
extent of sequence difference along the genome between SIVsun and other
primate lentiviruses was examined in diversity plots of concatenated Gag, Pol,
Vif, Env, and Nef protein sequences; in the regions of overlap between the Gag
and Pol, Pol and Vif, and Env and Nef coding sequences, the carboxy termini of
the Gag, Pol, and Env proteins were excluded. The fractional amino acid se-
quence difference was calculated for a window size of 200 residues, moved in
steps of 10 residues.
Phylogenetic relationships among the sequences were estimated by the neigh-
bor-joining and maximum-likelihood approaches. The neighbor-joining method
(59) was applied to protein distances with Kimura’s correction (40) and 1,000
bootstrap replicates and was implemented by using ClustalX (64). The maxi-
mum-likelihood method was implemented with PROTML (1) by using the JTT
model (39) with data frequencies. The order of sequence input was shuffled five
times, with the same best tree being found each time.
Nucleotide sequence accession number. The sequence of SIVsunl20L14/S2
has been submitted to GenBank under accession no. AF131870.
RESULTS
Plasma samples from 13 wild-caught African monkeys, in-
cluding 2 sun-tailed monkeys, were tested for SIV-specific an-
tibodies. As shown in Table 1, plasma from three Campbell’s
monkeys (Cercopithecus campbelli) and one sun-tailed monkey
(Cercopithecus lhoesti solatus) had cross-reactive antibodies to
SIVagm, SIVsm, or HIV-1 and HIV-2, with ELISA titers
against SIVagm ranging from 1:3,000 to 1:5,000. Whereas
plasma from the seropositive sun-tailed monkey cross-reacted
solely with gp160 of SIVsm and HIV-1/HIV-2, plasma from
two of the three seropositive Campbell’s monkeys additionally
cross-reacted with the major core protein p27 of SIVagm and
SIVsm. Interestingly, all the monkeys were negative for anti-
bodies to HTLV-1 and HTLV-2 (Table 1). The seropositive
sun-tailed monkey was of particular interest since this species
is a member of the same superspecies as the l’hoest monkey,
the source of the recently described SIVlhoest isolate (28).
Isolation of SIV from PBMC of this sun-tailed monkey was
therefore attempted by cocultivation with the human CD41
cell lines, C8166 or M4C8. Virus was successfully isolated, as
evidenced by the presence of RT activity in culture superna-
tants by 2 weeks after cocultivation with either of these two
human T-cell lines, and the new virus isolate was designated
SIVsun. Several attempts to isolate SIV from the three Camp-
bell’s monkeys by cocultivation of whole PBMC with different
human T-cell lines (C8166, M4C8, and CEMss) and of CD8-
depleted PBMC with a herpesvirus saimiri-transformed CD41
cell line from a seronegative Campbell’s monkey were unsuc-
cessful.
Host range of SIVsun in human CD41 cell lines and monkey
PBMC. The tropism of SIVsun for human T-cell lines was
compared with that of SIVlhoest and SIVagm. The human
CD41 cell lines, MT2, MT4, H9, U937, SupT1, C8166, CEMss,
CEM174, PM1, Hut78, and M4C8 were infected with an MOI
of 0.01 of uncloned, cell-free SIVagmVer90, SIVlhoest, and
SIVsun produced in CEMss cells, and culture supernatants
were evaluated for RT activity for 4 weeks. After infection with
SIV and extensive washing with HBSS, all RT activities were
below 300 cpm per ml. Subsequent RT activity of less than
1,000 cpm per ml was considered negative. The RT activities
shown in Table 2 represented peak levels 1 or 2 weeks after
infection. All three viruses replicated in CEMss, M4C8, MT4,
SupT1, and C8166 cell lines with variable efficiency. None of
the viruses replicated in H9, U937, Hut78, or PM1 (a Hut78
derivative) cell lines. Some of the cell lines, such as MT2
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(SIVagm) and CEMx174 (SIVlhoest), were variably infected
with one or more of the viruses.
The replication capacity of SIVsun was also assessed in
primary PHA-stimulated PBMC from rhesus macaques (Ma-
caca mulatta), pigtailed macaques (M. nemestrina), and patas
monkeys (Erythrocebus patas). Culture supernatant was col-
lected every 2 days with a complete medium change, and thus
the measured RT activities in Fig. 1 represent newly produced
virus. SIVsun replicated efficiently in PBMC from rhesus, pig-
tailed, and patas monkeys, with peak levels achieved as early as
4 days after infection (Fig. 1). PBMC from both rhesus ma-
caques showed similar susceptibility to SIVsun, whereas
PBMC from one each of the two pigtailed macaques and patas
monkeys were considerably less susceptible to infection. Stud-
ies to determine the replication kinetics in human PBMC are
in progress.
Characteristics of natural infection of sun-tailed monkeys
with SIVsun. The sun-tailed monkey that was the source of the
SIVsun isolate was born in 1989 in the Foreˆt des Abeilles in
Gabon, caught at the age of 15 days, and shipped to the
Primate Facility in France. During captivity, the monkey had
contact with only two other sun-tailed monkeys, one of which
is SIV seronegative and one of which had an unknown SIV
status, thereby excluding cross-species transmission. As ob-
served with other African monkeys naturally infected with SIV,
this monkey was apparently healthy, and signs of immunode-
ficiency, such as weight loss, diarrhea, or opportunistic infec-
tions were not observed.
To gather information on natural SIV infection, the charac-
teristics of the immune response and the distribution of lym-
phocyte subsets were evaluated. Fluorescence-activated cell
sorter analysis was used to determine the lymphocyte subsets in
both the seronegative and seropositive sun-tailed monkeys.
The absolute numbers of CD41 cells were slightly smaller in
the SIV-infected than in the noninfected monkey (391 and
516/ml of blood, respectively [Table 3]), but this difference was
unlikely to be significant. CD81 lymphocyte numbers exceeded
CD41 lymphocyte numbers, leading to an inverted CD4/CD8
ratio (0.9 and 0.7). Unlike African green monkeys, in which
CD41 lymphocytes routinely coexpress the CD8a antigen (2, 7,
14, 48, 57), CD41 CD81 double-positive PBMC did not exceed
1% for either of these two sun-tailed monkeys.
In terms of serologic response, Western blot analysis of the
plasma sample from the seropositive sun-tailed monkeys dem-
onstrated only antibodies cross-reactive with envelope proteins
of SIVagm or HIV-2 (Table 1). Weak Gag-specific antibody
responses are also characteristic of naturally infected African
green monkeys. Since the sera of the naturally infected sun-
tailed monkey showed strong binding to the SIVsun envelope
proteins, the ability of these sera to neutralize 100 TCID50 of
SIVsun was evaluated by using PHA-stimulated PBMC from
pigtailed macaques as target cells. Neutralizing activity in three
different plasma samples was not demonstrable even with a 1:2
dilution of these samples (data not shown).
Antigenic cross-reactivity between SIVsun and other pri-
mate lentiviruses. Immunoprecipitation of SIV antigens from
radiolabeled cell lysates of cells infected with either SIVsun
(Fig. 2A) or SIVsm (Fig. 2B) was used to evaluate the anti-
genic relationship of SIVsun to other SIV and HIV isolates. A
range of antisera from the SIV-infected monkeys (SIVsun,
SIVlhoest, SIVsm, SIVmac, and SIVagm) and HIV-infected
humans (HIV-2 and HIV-1) were used in this assay. Plasma of
the SIVsun-infected monkey immunoprecipitated the enve-
lope proteins of SIVsun but did not react with SIVsun Gag
proteins. The Gag proteins (a 55-kDa precursor and a 27-kDa
protein) of SIVsun could be seen by immunoprecipitation with
plasma samples from a SIVlhoest-infected macaque. This sam-
ple also reacted with the envelope proteins of SIVsun. In
contrast, antisera specific for SIVagm, SIVsm, SIVmac, HIV-1,
and HIV-2 reacted primarily with the Gag proteins and only
weakly with envelope proteins. The weakest antigenic cross-
TABLE 2. Host range of uncloned SIVagm90, SIVlhoest, and
SIVsun in different human T-cell lines
Cell line
RT activitya of:
SIVagm90 SIVlhoest SIVsun
MT2 1 2 2
C8166 11 1 1
H9 2 2 2
MT4 1 111 111
U937 2 2 2
SupT1 111 1 11
PM1 2 2 2
Hut78 2 2 2
Molt4cl8 1 1 11
CEMss 111 11 111
CEM174 2 1 2
a RT activities represent peak values 1 or 2 weeks after infection with a MOI
of 0.01. 2, 0 to 1,000 cpm/ml; 1, 1,001 to 5,000 cpm/ml; 11, 5,001 to 20,000
cpm/ml; 111, .20,000 cpm/ml.
FIG. 1. Infection of PHA-stimulated PBMC from rhesus (Rh), pigtailed
(PT), and patas (PatM.) monkeys with uncloned SIVsun (MOI, 0.01). The virus
stock was produced on CEMss cells. PBMC were infected for 4 h, washed three
times with HBSS, and then resuspended in 3 ml of RPMI complete medium.
Cell-free supernatants were taken at regular intervals for the measurement of
RT activity combined with a complete exchange of medium.
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reactivity was observed for antisera specific to HIV-1 and
HIV-2. These data suggest a closer antigenic relationship be-
tween SIVsun and SIVlhoest.
To confirm the antigenic relationships between SIVsun and
SIVsm/SIVmac, SIVsmH4-infected cell lysates were used as
the source of antigen, as shown in Fig. 2B. The SIVsun and
SIVlhoest-specific samples cross-reacted weakly with the Env
proteins of SIVsm. Due to the lack of Gag-specific antibodies
in the plasma sample from the SIVsun-infected monkey, Gag
antigens were not observed for these immunoprecipitations. In
contrast, sera specific for viruses of the SIVsm lineage (SIVsm,
SIVmac, and HIV-2) precipitated the Gag, Pol, and Env pro-
teins of SIVsm, demonstrating the close antigenic relationship
between these viruses. Interestingly, the SIVagm-specific
plasma also cross-reacted with SIVsm Env glycoproteins de-
spite the distant antigenic and genetic relationship between
SIVsm and SIVagm. As also observed for the SIVsun cell
lysates in Fig. 3A, HIV-1-specific plasma cross-reacted weakly
with the SIVsmH4 Env proteins. A faint reaction to p27 in the
plasma of the SIV-positive sun-tailed monkey could be de-
tected by SIVsun-specific Western blotting but the band was
much weaker than that corresponding to the reaction of
plasma of SIVlhoest- or SIVagm3-infected pigtailed macaques
(data not shown).
SIVsun is a novel member of the SIVmnd/SIVlhoest lineage.
Assuming a closer genetic relationship between SIVsun,
SIVlhoest, and SIVmnd, primers spanning the primer binding
site and the gag gene were chosen from sequences conserved
between SIVlhoest and SIVmnd. A 1,856-bp fragment was
amplified by PCR from cellular DNA extracted from infected
C8166 cells and cloned. This gag fragment was used for sub-
sequent Southern blot hybridization to identify restriction en-
zymes useful for cloning and as a probe to identify proviruses
within a bacteriophage lambda library generated by EcoRI
digestion of cellular DNA extracted from infected C8166 cells.
Six clones hybridizing with the gag-specific viral probe were
obtained, and one, which contained a 8.6-kb viral fragment,
was used to generate a full-length replication-competent clone
of SIVsun. The 39 part of the virus (1.4 kb), which was ab-
sent from the lambda clone, was generated by PCR and ligated
into the linearized recombinant plasmid containing the 8.6-kb
viral fragment to generate the full-length molecular clone
SIVsunl20(L14/S2).
SIVsunl20(L14/S2) was infectious after transfection of
CEMss cells (data not shown). The clone was sequenced in its
entirety (10,006 nucleotides [nt]) and compared to other pri-
mate lentiviruses. The genomic organization of SIVsun was
similar to that of SIVlhoest, SIVmnd, SIVagm, and SIVsyk.
FIG. 2. RIPA of viral proteins. CEMss cells infected with SIVsun (A) or CEM174 cells infected with SIVsmH4 (B) were labeled overnight with L-[35S]methionine
and L-[3535S]cysteine (Amersham), lysed, and precipitated with plasma from different monkeys. a-SIVsun plasma was derived from two separate bleedings of the
naturally infected sun-tailed monkey [a-SIVsun(1) and a-SIVsun(2)]; a-SIVlhoest, a-SIVagm, a-SIVsm, and a-SIVmac plasma were collected from experimentally
SIV-infected macaques; and a-HIV-1 and a-HIV-2 plasma originated from infected humans.
TABLE 3. Lymphocyte subsets in two wild-caught sun-
tailed monkeys
Subset
Value in:
SIV-negative
monkey
SIV-positive
monkey
Lymphocytes (%) 34.7 23.7
CD31 lymphocytesa (%) 54.6 56.1
CD41 lymphocytesb (%) 36.3 31.8
CD81 lymphocytesc (%) 40.8 46.2
CD41 CD81 lymphocytes (%) 1.0 1.2
CD201 lymphocytesd (%) 15.6 11.9
Leukocytes (cells/ml) 4,100 5,190
Lymphocytes (cells/ml) 1,423 1,230
CD31 lymphocytes (cells/ml) 777 690
CD41 lymphocytes (cells/ml) 516 391
CD81 lymphocytes (cells/ml) 580 568
CD201 lymphocytes (cells/ml) 222 146
a Rhesus anti-CD3–PE (M. Rosenzweig, Harvard University).
b OKT4A-FITC (Ortho Diagnostic Systems, Raritan, N.J.).
c Leu2A-PerCP (Becton Dickinson, Franklin Lakes, N.J.).
d Leu16-FITC (Becton Dickinson).
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FIG. 3. Diversity plots. (A) Plots comparing SIVsun with representatives of the five major lineages of primate lentiviruses, i.e., SIVlhoest, SIVmnd, SIVsyk,
SIVagm(Ver), SIVsm(PBj), and SIVcpz(Gab). (B) Plots comparing SIVsun with SIVlhoest, SIVsun with SIVmnd, SIVlhoest with SIVmnd, and SIVagm(Gri) with
SIVagm(Ver). The protein sequence difference is plotted for windows of 200 amino acids moved in steps of 10.
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Each of these viruses encodes gag, pol, and env, as well as the
accessory genes vif, vpr, tat, rev, and nef, but lacks the addi-
tional genes vpu (found only among the members of the HIV-
1/SIVcpz lineage) and vpx (specific to the members of the
HIV-2/SIVsm lineage). The LTR of SIVsun (769 nt) contained
all the characteristic features of other primate lentivirus LTRs.
Similar to the LTRs of the other members of the SIVmnd
lineage (SIVmnd and SIVlhoest), the LTR of SIVsun con-
tained one NF-kB site and two potential SP-1 binding sites
(data not shown).
Comparisons of the predicted protein sequences encoded by
the eight common genes revealed that SIVsun was much more
similar to SIVlhoest than to any other SIV (Table 4). For the
larger proteins at least, the next most similar virus was
SIVmnd; this is as expected, since SIVlhoest and SIVmnd were
previously found to be members of the same major lineage
(28). The nature of the divergence between SIVsun and other
SIVs was also examined in diversity plots, depicting the extent
of sequence difference for windows of 200 amino acids along
the concatenated predicted gene products (or, for simplicity,
the proteome). Such diversity plots are useful in highlighting
viral sequences that may have undergone recombination in the
past (19): mosaic sequences generated by ancestral recombi-
nation exhibit different relative extents of divergence from
other sequences. The plots confirmed that SIVsun is consis-
tently much less divergent from SIVlhoest than from other
SIVs throughout most of the proteome. However, the plots
also revealed one region, of about 100 residues near the
beginning of the reverse transcriptase region of Pol, where
SIVsun, SIVlhoest, and SIVmnd are approximately equidistant
(Fig. 3A; see also Fig. 3B).
To investigate whether the SIVsun, SIVlhoest, and SIVmnd
lineages had recombined at some point, phylogenetic analyses
were conducted for the same moving windows of 200 amino
acids. Fifteen HIV and SIV sequences were included (as in Fig.
4) and 100 bootstrap replicates were performed for each of the
182 windows examined, and so the neighbor-joining method
was used. For all 182 windows, SIVsun, SIVlhoest, and
SIVmnd formed a clade which in most cases (142 windows)
was supported by high bootstrap values (.80%). In all but
eight consecutive windows, SIVsun and SIVlhoest were more
closely related to each other than to SIVmnd, with high boot-
strap support in the vast majority of cases (160 of 174). Within
the exceptional region of 270 residues highlighted in the di-
versity plot (Fig. 3A), alternative branching orders were found,
with SIVmnd clustering with either SIVsun or SIVlhoest. The
bootstrap values for these alternative topologies ranged be-
tween 48 and 71%. This exceptional region was investigated
further by maximum-likelihood phylogenetic analysis of mov-
ing windows of 300 amino acids from just four sequences, namely,
SIVsun, SIVlhoest, SIVmnd, and an outgroup (SIVagmVer).
Moving in steps of 10 amino acids, there were only three
windows in which the tree clustering SIVsun and SIVlhoest
was not optimal, and in each case the (suboptimal) tree in
which SIVsun and SIVlhoest clustered was less than one stan-
dard error worse than the optimal tree. This Kishino and
Hasegawa maximum-likelihood test (41) indicated that this
change in branching order was not significant. Thus, there was
no significant support for recombination, and we conclude that
the diversity plots are highlighting a region that has been un-
usually highly conserved in the SIVmnd lineage. Therefore, to
summarize the phylogenetic position of SIVsun, we performed
a maximum-likelihood analysis on a concatenated Gag-Pol-
Vif-Env-Nef protein alignment. As shown in Fig. 4, the results
confirmed that SIVsun is a member of the same major lineage
as SIVmnd and SIVlhoest and that within that lineage SIVsun
and SIVlhoest are clearly the more closely related pair.
The degree of protein sequence similarity between SIVsun
and SIVlhoest was also compared to that seen in the other
cases where different lineages of SIV have been found within a
species or superspecies, namely, in African green monkeys and
in chimpanzees (Table 5). Overall, the extent of sequence
identity between SIVsun and SIVlhoest was very similar to that
found among SIVagm isolates from vervet, grivet, and tantalus
monkeys. The extent of divergence between SIVcpz from dif-
TABLE 5. Percent protein sequence identities within primate
lentivirus lineages
Comparison
% Identity in:
Gag Pol Vif Vpr Tat Rev Env Nef
SIVsun vs SIVlhoest 71 73 52 63 46 46 67 56
SIVagmTan vs SIVagmVer 73 69 60 82 54 53 66 63
SIVagmGri vs SIVagmVer 71 71 53 70 52 50 68 70
SIVagmTan vs SIVagmGri 78 67 54 69 62 44 63 69
SIVcpzGab vs SIVcpzAnt 67 73 54 63 59 43 49 52
TABLE 4. Percent protein sequence identities between SIVsun and
other SIVs
SIV
% Identity to SIVsun in:
Gag Pol Vif Vpr Tat Rev Env Nef
SIVlhoest 71 73 52 63 46 46 67 56
SIVmnd 56 66 34 50 32 39 48 48
SIVsyk 46 49 30 25 29 13 35 34
SIVagm 53 56 29 40 40 31 33 39
SIVsm 52 54 33 40 33 26 34 43
SIVcpz 50 57 31 38 27 17 30 43
FIG. 4. Phylogenetic relationship of SIVsun (boxed) to other primate lenti-
viruses. The tree was derived by the maximum-likelihood analysis of a concate-
nated Gag-Pol-Vif-Env-Nef protein alignment (see the text for details). A tree
derived by neighbor-joining analysis differed in no significant way. Stars indicate
that the clade to the right was found in 100% of bootstrap replicates of the
neighbor-joining analysis. Horizontal branch lengths are drawn to scale, with the
bar indicating 0.1 amino acid replacement per site.
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ferent subspecies of chimpanzee was also similar, except in the
envelope protein. In diversity plots (Fig. 3B), the extent of
sequence difference between SIVsun and SIVlhoest was re-
markably similar to that between two SIVagm lineages (the
plot shown is for vervet versus grivet SIV). Parallel fluctuations
in the two plots along the proteome are consistent with diver-
gence of the two pairs of sequences over approximately the
same timescale and suggest that similar selective constraints
have operated on the genome within the two different SIV
lineages.
The envelope proteins of SIVsun and SIVlhoest are partic-
ularly well conserved, being little more divergent overall than
the Pol protein (Table 4 and Fig. 3A). The similarity among
SIVsun, SIVlhoest, and SIVmnd is illustrated in an alignment
of the surface unit (gp120) portion of the Env protein (Fig. 5).
Although scattered amino acid replacements are evident
FIG. 5. Comparison of the predicted protein sequence of the surface subunit of the envelope of SIVsun, SIVlhoest, and SIVmnd reveals remarkable conservation
of cysteine residues and regions such as the V3 loop homolog and the CD4 binding. Conserved cysteines are boxed. Potential N-linked glycosylation sites are underlined.
The predicted sequence of gp120 of SIVsunl20L14/S2 molecular clone is shown at the top. Substitutions relative to this sequence in the predicted sequence of gp120
of SIVlhoest and SIVmnd are aligned below. Dots indicate amino acid identity at a residue, and dashes indicate gaps introduced to optimize alignment. Variable regions
analogous to those observed in HIV-1 and other SIVs are indicated, and the cleavage site for the transmembrane glycoprotein (TM) is shown.
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throughout gp120, 20 cysteine residues (boxed) and 10 poten-
tial N-linked glycosylation sites (underlined) are conserved
among all three sequences. In addition, the regions homolo-
gous to the V3 loop and the CD4 binding domain are remark-
ably highly conserved, with only four and three differences,
respectively, between SIVsun and SIVlhoest. The most vari-
able regions are V1 and V4, which exhibit characteristic inser-
tion-deletion differences.
DISCUSSION
Recently we described SIVlhoest isolated from the l’hoest
monkey, the nominal member of the l’hoest superspecies in-
habiting mountain and lowland forests along the right bank of
the Congo River (Uganda to Congo) (28). SIVlhoest unexpect-
edly showed the closest genetic relationship to SIVmnd-GB1,
the only full-length SIV characterized so far from a naturally
infected mandrill (Mandrillus sphinx) from Gabon (67). The
relationship between SIVlhoest and SIVmnd presented an
enigma. It could not be explained by host-dependent evolution,
since mandrills and l’hoest monkeys are phylogenetically dis-
tant species within the Cercopithecinae; mandrills are closer to
the mangabeys (Cercocebus species) than to the guenons (Cer-
copithecus and Chlorocebus) (25). Nor could it be explained by
recent cross-species transmission, since mandrills and l’hoest
monkeys presently inhabit geographically separate regions of
Africa. However, SIVmnd could have been derived from cross-
species transmission of SIV from one of the other members of
the l’hoest superspecies, either C. lhoesti preussi or C. lhoesti
solatus, whose ranges overlap that of the mandrill (Fig. 6A).
Such a scenario is plausible since mandrills and these guenons
share some ecological characteristics, including a mainly ter-
restrial way of life. In the present study, we have isolated an
SIV from one of these other members of the l’hoest superspe-
cies, the sun-tailed monkey, C. lhoesti solatus. This virus, SIV-
sun, was distinct from but most closely related to SIVlhoest.
Therefore, SIVsun is more distantly related to SIVmnd and
could not have been the proximal source of SIVmnd.
It is important to recognize that the fairly distant relation-
ship between naturally occurring African SIV isolates within a
lineage underscores the ancient nature of these viruses. The
genetic relationship between SIVsun and SIVlhoest is similar
to the diversity among the four different subtypes of SIVagm
(vervet, grivet, tantalus, and sabaeus) (4, 6, 12, 15, 16, 32, 36,
38, 47). However, while the four species of African green
monkeys inhabit different geographic regions of Africa, there
are still areas of overlap between vervet, grivet, and tantalus
species that could potentially allow transmission of viruses
between species (Fig. 6B). The separation between the habitats
of l’hoest monkeys, sun-tailed monkeys, and Preuss’s monkeys
is far more pronounced. To date, C. lhoesti solatus has an
isolated distribution within Gabon and is separated by 600 km
from C. lhoesti preussi in the northwest and by 1,600 km from
C. lhoesti lhoesti in the east. These forested areas in Gabon,
eastern Zaire, and the highlands of Cameroon are believed to
have been connected in the past, and several theories have
been proposed for how they were separated by the contraction
and disintegration of tropical rainforest in Africa. These events
are believed to have resulted in the isolation and speciation of
the guenons over the last 1 million years (23, 26). The genetic
relationship between SIVlhoest and SIVsun suggests that an
ancestral SIV most probably infected an ancestral monkey
before the vegetation changes and subsequent speciation
events. The distant relationship of SIVmnd to SIVlhoest and
SIVsun within the same lineage could be explained by the
transmission of SIV to mandrills from (i) an ancestor of the
l’hoest superspecies before the division into the three distinct
species occurred, (ii) Preuss’s monkey (mandrills and Preuss’s
monkeys share the same habitat), or (iii) a yet unidentified
species. It may be possible to discriminate among these three
hypotheses by characterizing SIVs from Preuss’s monkeys and
other monkeys that share the same habitat as mandrills and by
characterizing more SIVs from mandrills.
The host-dependent divergence of SIVsun and SIVlhoest
suggested above has implications for the timescale of HIV and
SIV evolution. The date of emergence of the common ancestor
of the various major lineages of primate lentiviruses has been
estimated previously by molecular clock extrapolations, yield-
ing estimates ranging from the 1940s (63) to 150 to 200 years
ago (56, 61). The demonstration of HIV-1 infection in 1959,
with the implication that the M group of HIV-1 arose even
earlier, indicates that the former estimate is much too recent
(70). The findings of related but divergent SIV lineages within
the C. lhoesti superspecies, as well as within the African green
monkey superspecies (4, 6, 12, 15, 16, 32, 36, 38, 47) and in
different subspecies of the chimpanzee Pan troglodytes (19), are
FIG. 6. Schematic views of Africa showing the ranges occupied by l’hoest monkeys (C. lhoest lhoesti) and their close relatives, Preuss’s monkeys (C. lhoest preussi),
and sun-tailed monkeys (C. lhoesti solatus) (the distribution of mandrills [Mandrillus sphinx] is indicated by cross-hatching) (A) and the geographic distribution of the
four African green monkey species, i.e., the grivet (C. aethiops), tantalus (C. tantalus), vervet (C. pygerythrus), and sabaeus monkeys (C. sabaeus) (B) (44).
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all consistent with divergence events within major SIV lineages
having occurred tens or even hundreds of thousands of years
ago. Thus, even the estimates of 150 to 200 years ago may be
out by several orders of magnitude. Variations in the rate of
evolution among different HIVs and SIVs could contribute to
the error in these molecular clock estimates (42, 60), but they
seem inadequate to explain the magnitude of the discrepancy.
Alternatively, the extent of genetic divergence among lineages
of SIV might have been underestimated because standard
methods of “correcting” for multiple hits ignore variation in
the rates at which substitutions accumulate at different resi-
dues (43, 60).
The identification of SIV infection in another African mon-
key species provided the opportunity to examine some of the
virologic and immunologic characteristics of asymptomatic
natural infection. One characteristic of SIVsun infection,
which is frequently observed in other naturally infected Afri-
can monkeys, was the very weak anti-Gag antibody response in
the SIV-infected sun-tailed monkey. It has been reported that
naturally SIV-infected sooty mangabeys, Sykes monkeys, one
mandrill, and especially African green monkeys frequently ex-
hibit a low reactivity to Gag antigens by ELISA, RIPA, and/or
Western blotting (3, 13, 17, 47, 49, 58, 66). The low anti-Gag
response in SIV natural monkey hosts was particularly striking
compared to the strong anti-Gag response that develops when
heterologous hosts, such as macaques, are inoculated with the
same virus (Fig. 2A) (17, 29, 49). The reason for the small
amount of Gag-specific antibodies in SIV-infected African
monkeys is still unclear. Since SIV-infected sooty mangabeys
have been reported to show relatively high cellular and plasma
virus loads (105 to 107 RNA copies per ml of plasma) (17, 58),
this difference cannot simply be explained by differences in
virus load. Another serologic similarity to naturally SIV-in-
fected sooty mangabeys and African green monkeys (5, 17, 49)
was the apparent lack of neutralizing antibodies against the
homologous SIV isolate despite the presence of envelope-
specific antibody and long-term infection with the virus without
clinical disease development. In addition, despite lifelong SIV
infection, the SIV-positive sun-tailed monkey did not exhibit
signs of immunodeficiency or opportunistic infections.
In summary, we demonstrated that SIVsun is a novel mem-
ber of the SIVmnd/SIVlhoest lineage, with closer relationship
to SIVlhoest than to SIVmnd. The identification of highly
related viruses within two members of a superspecies suggests
that the lineage previously thought to originate in mandrills
actually appears to have evolved within monkeys of the C.
lhoesti superspecies. We therefore propose that the SIVmnd
lineage should be redesignated the SIVlhoest lineage. This
new SIV-host system offers an additional model for studying
host-virus adaptation and may give insights into the age, origin,
and evolution of SIVs in Africa.
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